References
- Frank A. Zimpel. Trisomie 21. Was wir von Menschen mit Down-syndrome lernen konnen 2000 Personen und ihre Neurophysiologischen Befunde. 1 AuflageVandenhoeck Ruprecht Gottingen 2016, ISBN 978-3-525-70175-1.
- Barkin RM, Weston WL, Humbert JR, Maire F. Phagocytic function in Down syndrome – I. Chemotaxis. J MentDeficRes 1980; 24:243–9.
- Barroeta O, Nungaray L, López-Osuna M, Armendares S, Salamanca F, Kretschmer RR. Defective monocyte chemotaxis in children with Down’s syndrome. Pediatr Res 1983; 17:292–5.
- Cetiner S, Demirhan O, Inal TC, et al. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. Int J Immunogenet. 2010;37(4):233-7.
- Etta W. Sprach for derung by Kindern mit Down-Syndrom. 14 Auflage Kohlhammer Stuttgart 2022. ISBN 978-3-17-020148-4.
- Fergus K. How Down syndrome is diagnosed [Internet]. Very-well Health. 2023. Available from: https://www.verywellhealth.com/diagnosing-down-syndrome-1120396
- Guazzarotti L, Trabattoni D, Castelletti E, et al. T lymphocyte maturation is impaired in healthy young individuals carrying trisomy 21 (Down syndrome). Am J Intellect Dev Disabil 2009; 114:100–9.
- Jovanovic SV, Clements D, MacLeod K. Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 1998; 25:1044–8.
- Monpierre L, Ait-Ammar N, Valsecchi I, et al. Species identification and invitro antifungal susceptibility of Paecilomyces/Purpure ocilliumspecies isolated from clinical respiratory samples: a multicenter study. J Fungi (Bael) 2022; 8:684).
- Nisihara RM, Utiyama SR, Oliveira NP, Messias-Reason IJ. Mannan-binding lectin deficiency increases the risk of recurrent infections in children with Down’s syndrome. Hum Immunol 2010; 71:63–6.
- Rigas D, Elsasser P, Hecht F. Impaired in vitro response of circulating lymphocytes to phytohemagglutinin in Down’s syndrome: dose and time–response curves and relation to cellular immunity. Int Allergy Immunol 1970; 39:587–608.
- Selikowitz M. Health problems and health checks in schoolaged children with Down syndrome. J Pediatr Child Health 1992; 28:383–6.
- Van Trotsenburg AS, Heymans HS, Tijssen JG et al. Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome. Pediatrics 2006; 118:1633–9.
- Wolfgan Storm. Das Down Syndrom. Medizinische Betreuung vom Kindes bis zum Erwachsenen alterWissenschaftlicheVerlags – Gesellschaft, Stuttgart 1995 ISBN 3-8047-1407-2.
- Data and Statistics on Down Syndrome, Center for disease, control and prevention. [Internet], Available at: https://bit.ly/3wafyrR
- Castelli MV, Alastruey-Izquierdo A, Cuesta I et al. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrobe Agents chemoter 2008; 52-2926-8.
- Mekov E, Petkov R, Tsakova A, et al. Two-year mortality following a severe COPD exacerbation in Bulgarian patients. Acta Medica Bulgarica, 2022, 49(2): 33-38
- Yankov G, Alexieva M, Yankova S, Mekov E. Postpneumonectomy empyema following SARS-CoV-2 infection in a patient with metastatic lung cancer. Acta Medica Bulgarica, 2022, 49(2): 39-42
- Alexieva M, Serkedzhiev I, Cherneva R, et al. Chronic necrotizing pulmonary aspergillosis after SARS-Cov-2 infection – a case report. Acta Medica Bulgarica, 2023, 50(3): 57-61
- Zuhair M, Nas A, Lautan R, et al. Implementation of early detection of lung tuberculosis using WHO systematic screening guidelines at the public health center in Indonesia. ActaMedicaBulgarica, 2024, 51(3):6-11